Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway - Wei, Xuan; Shi, Juanjuan; Lin, Qianhan; Ma, Xiaoxue; Pang, Yingxin; Mao, Hongluan; Li, Rui; Lu, Wei; Wang, Yu; Liu, Peishu (Frontiers in Oncology, 2021)